Literature DB >> 28213156

Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Kevin Yum1, Eric T Wang2, Auinash Kalsotra3.   

Abstract

Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease primarily characterized by myotonia and progressive muscle weakness. The pathogenesis of DM involves microsatellite expansions in noncoding regions of transcripts that result in toxic RNA gain-of-function. Each successive generation of DM families carries larger repeat expansions, leading to an earlier age of onset with increasing disease severity. At present, diagnosis of DM is challenging and requires special genetic testing to account for somatic mosaicism and meiotic instability. While progress in genetic testing has been made, more rapid, accurate, and cost-effective approaches for measuring repeat lengths are needed to establish clear correlations between repeat size and disease phenotypes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28213156      PMCID: PMC5447468          DOI: 10.1016/j.gde.2017.01.007

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  67 in total

1.  Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1.

Authors:  Walther J A A van den Broek; Marcel R Nelen; Godfried W van der Heijden; Derick G Wansink; Bé Wieringa
Journal:  FEBS Lett       Date:  2006-09-05       Impact factor: 4.124

Review 2.  Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature.

Authors:  Susan Zeesman; Nancy Carson; Donald T Whelan
Journal:  Am J Med Genet       Date:  2002-01-22

Review 3.  Repeat expansion disease: progress and puzzles in disease pathogenesis.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 4.  Congenital and infantile myotonic dystrophy.

Authors:  Bernard Echenne; Guillaume Bassez
Journal:  Handb Clin Neurol       Date:  2013

5.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

6.  Saccharomyces cerevisiae flap endonuclease 1 uses flap equilibration to maintain triplet repeat stability.

Authors:  Yuan Liu; Haihua Zhang; Janaki Veeraraghavan; Robert A Bambara; Catherine H Freudenreich
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Hairpin structure-forming propensity of the (CCTG.CAGG) tetranucleotide repeats contributes to the genetic instability associated with myotonic dystrophy type 2.

Authors:  Ruhee Dere; Marek Napierala; Laura P W Ranum; Robert D Wells
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

8.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

9.  Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Authors:  Stéphane Jean; Louis Richer; Luc Laberge; Jean Mathieu
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

10.  Technical standards and guidelines for myotonic dystrophy type 1 testing.

Authors:  Thomas W Prior
Journal:  Genet Med       Date:  2009-07       Impact factor: 8.822

View more
  29 in total

1.  Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.

Authors:  Gayle Overend; Cécilia Légaré; Jean Mathieu; Luigi Bouchard; Cynthia Gagnon; Darren G Monckton
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

Review 2.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

3.  Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.

Authors:  JuYeon Lee; Yugang Bai; Ullas V Chembazhi; Shaohong Peng; Kevin Yum; Long M Luu; Lauren D Hagler; Julio F Serrano; H Y Edwin Chan; Auinash Kalsotra; Steven C Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

4.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

Review 5.  Post-transcriptional regulation of gene expression and human disease.

Authors:  Anita H Corbett
Journal:  Curr Opin Cell Biol       Date:  2018-03-06       Impact factor: 8.382

Review 6.  Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions.

Authors:  Ginny R Morriss; Thomas A Cooper
Journal:  Hum Genet       Date:  2017-05-08       Impact factor: 4.132

7.  Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.

Authors:  Ariadna Bargiela; Maria Sabater-Arcis; Jorge Espinosa-Espinosa; Miren Zulaica; Adolfo Lopez de Munain; Ruben Artero
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

8.  CBRPP: a new RNA-centric method to study RNA-protein interactions.

Authors:  Yunfei Li; Shengde Liu; Lili Cao; Yujie Luo; Hongqiang Du; Siji Li; Zeming Zhang; Xuefei Guo; Wenmin Tian; Catherine Cl Wong; Fuping You
Journal:  RNA Biol       Date:  2021-02-17       Impact factor: 4.652

9.  Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.

Authors:  Ellen van der Plas; Laurie Gutmann; Dan Thedens; Richard K Shields; Kathleen Langbehn; Zhihui Guo; Milan Sonka; Peggy Nopoulos
Journal:  Muscle Nerve       Date:  2021-02-05       Impact factor: 3.217

10.  RARE POMC MUTATION IN A PATIENT WITH MYOTONIC DYSTROPHY TYPE 1 AND ADRENOCORTICOTROPIN HYPERRESPONSE TO CORTICOTROPIN-RELEASING HORMONE.

Authors:  Silvia Cantara; Francesco Chiofalo; Cristina Ciuoli; Carlotta Marzocchi; Maria Teresa Dotti; Maccora Carla; Maria Grazia Castagna; Fabio Giannini
Journal:  AACE Clin Case Rep       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.